Adaptive Estimation of Personalized Maximum Tolerated Dose in Cancer Phase I Clinical Trials Based on All Toxicities and Individual Genomic Profile

BACKGROUND: Many biomarkers have been shown to be associated with the efficacy of cancer therapy. Estimation of personalized maximum tolerated doses (pMTDs) is a critical step toward personalized medicine, which aims to maximize the therapeutic effect of a treatment for individual patients. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhengjia, Li, Zheng, Zhuang, Run, Yuan, Ying, Kutner, Michael, Owonikoko, Taofeek, Curran, Walter J., Kowalski, Jeanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5268707/
https://www.ncbi.nlm.nih.gov/pubmed/28125617
http://dx.doi.org/10.1371/journal.pone.0170187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5268707/
https://www.ncbi.nlm.nih.gov/pubmed/28125617
http://dx.doi.org/10.1371/journal.pone.0170187

Ejemplares similares